Capsules 10mg, 18mg, 25mg, 40mg, 60mg

ADHD

 Restricted to initiation by child or adolescent psychiatrists or paediatricians
experienced in the management of ADHD.

Tablets 25 micrograms

ADHD (unlicensed indication).

Tablets 5mg, 10mg, 20mg

ADHD

M/R tablets 1mg, 2mg, 3mg, 4mg

For use in children and adolescents 6 - 17 years for whom stimulants are not suitable, not tolerated or have shown to be ineffective.

Specialist initiation only.

Adult Hard Capsules 30mg, 50 mg and 70mg (Elvanse Adult)

Hard capsules 20mg, 30mg, 40mg, 50mg, 60mg, 70mg (Elvanse)

Lisdexamfetamine (Elvanse) is recommended for use in the treatment of ADHD in children and young adults only in complex patients who meet both of the following criteria.
- extenuating circumstances exist which mean that a patient would not reliably receive all the required doses of dexamfetamine throughout the day and requires a once daily dose of lisdexamfetamine to support adherence
- treatment has been agreed through the internal governance arrangements of the trust.
  

Tablets 5mg, 10mg, 20mg
M/R tablets 18mg, 27mg, 36mg, 54mg
M/R capsules 5mg, 10mg, 20mg, 30mg, 40mg, 50mg, 60mg

The preferred cost-effective methylphenidate product is Xaggatin XL; this should be considered first line if considered suitable for a patient. Other methylphenidate brands are available if Xaggatin XL is unsuitable.

Certain methylphenidate products are in limited supply and may be out of stock due to on-going supply disruption; prescribe generically to enable switching between bioequivalent MR products where possible to do so.

For adult patients under the care of Psychiatry UK in South Cumbria, please prescribe as Xaggatin XL in primary care.

Tablets 100mg

Specialist initiation only.

Treatment of narcolepsy with or without cataplexy in adults

Tablets 75mg, 150mg

for NICE TA758:  Solriamfetol for excessive daytime sleepiness caused by narcolepsy

 for NICE TA777: Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoea